Understanding Platelet-Rich Fibrin. Richard J. Miron
Eng 2005;11:896–903.
20.Au P, Tam J, Fukumura D, Jain RK. Bone marrow-derived mesenchymal stem cells facilitate engineering of long-lasting functional vasculature. Blood 2008;111:4551–4558.
21.Clark RA. Fibrin and wound healing. Ann N Y Acad Sci 2001;936:355–367.
22.Shaikh FM, Callanan A, Kavanagh EG, Burke PE, Grace PA, McGloughlin TM. Fibrin: A natural biodegradable scaffold in vascular tissue engineering. Cells Tissues Organs 2008;188:333–346.
23.Nurden AT. Platelets, inflammation and tissue regeneration. Thromb Haemost 2011;105(suppl 1):S13–S33.
24.Fujioka-Kobayashi M, Miron RJ, Hernandez M, Kandalam U, Zhang Y, Choukroun J. Optimized platelet-rich fibrin with the low-speed concept: Growth factor release, biocompatibility, and cellular response. J Periodontol 2017;88:112–121.
25.Lozito TP, Taboas JM, Kuo CK, Tuan RS. Mesenchymal stem cell modification of endothelial matrix regulates their vascular differentiation. J Cell Biochem 2009;107:706–713.
26.Kato J, Tsuruda T, Kita T, Kitamura K, Eto T. Adrenomedullin: A protective factor for blood vessels. Arterioscler Thromb Vasc Biol 2005;25:2480–2487.
27.Shamloo A, Xu H, Heilshorn S. Mechanisms of vascular endothelial growth factor-induced pathfinding by endothelial sprouts in biomaterials. Tissue Eng Part A 2012;18:320–330.
28.Martin P, Leibovich SJ. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol 2005;15:599–607.
29.Tsirogianni AK, Moutsopoulos NM, Moutsopoulos HM. Wound healing: Immunological aspects. Injury 2006;37(suppl 1):S5–S12.
30.Adamson R. Role of macrophages in normal wound healing: An overview. J Wound Care 2009;18:349–351.
31.Davis VL, Abukabda AB, Radio NM, et al. Platelet-rich preparations to improve healing. Part I: Workable options for every size practice. J Oral Implantol 2014;40:500–510.
32.Davis VL, Abukabda AB, Radio NM, et al. Platelet-rich preparations to improve healing. Part II: Platelet activation and enrichment, leukocyte inclusion, and other selection criteria. J Oral Implantol 2014;40:511–521.
33.Ghasemzadeh M, Hosseini E. Intravascular leukocyte migration through platelet thrombi: Directing leukocytes to sites of vascular injury. Thromb Haemost 2015;113:1224–1235.
34.Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 1994;331:1286–1292.
35.Bowen T, Jenkins RH, Fraser DJ. MicroRNAs, transforming growth factor beta‐1, and tissue fibrosis. J Pathol 2013;229:274–285.
36.Babensee JE, McIntire LV, Mikos AG. Growth factor delivery for tissue engineering. Pharma Res 2000;17:497–504.
37.Giannobile WV, Hernandez RA, Finkelman RD, et al. Comparative effects of platelet-derived growth factor-BB and insulin-like growth factor-I, individually and in combination, on periodontal regeneration in Macaca fascicularis. J Periodontal Res 1996;31:301–312.
38.Eren G, Gurkan A, Atmaca H, Donmez A, Atilla G. Effect of centri-fugation time on growth factor and MMP release of an experimental platelet-rich fibrin-type product. Platelets 2016;27:427–432.
39.Miron RJ, Xu H, Chai J, et al. Comparison of platelet-rich fibrin (PRF) produced using 3 commercially available centrifuges at both high (~ 700 g) and low (~ 200 g) relative centrifugation forces. Clin Oral Investig 2020;24:1171–1182.
40.Davies C, Miron RJ. PRF in Facial Esthetics. Chicago: Quintessence, 2020.
41.Zhang J, Yin C, Zhao Q, et al. Anti-inflammation effects of injectable platelet-rich fibrin via macrophages and dendritic cells. J Biomed Mater Res A 2020;108:61–68.
42.Lucarelli E, Beretta R, Dozza B, et al. A recently developed bifacial platelet-rich fibrin matrix. Eur Cell Mater 2010;20:13–23.
43.Saluja H, Dehane V, Mahindra U. Platelet-rich fibrin: A second generation platelet concentrate and a new friend of oral and maxillofacial surgeons. Ann Maxillofac Surg 2011;1:53–57.
44.Miron RJ, Fujioka-Kobayashi M, Hernandez M, et al. Injectable platelet rich fibrin (i-PRF): Opportunities in regenerative dentistry? Clin Oral Investig 2017;21:2619–2627.
45.Abd El Raouf M, Wang X, Miusi S, et al. Injectable-platelet rich fibrin using the low speed centrifugation concept improves cartilage regeneration when compared to platelet-rich plasma. Platelets 2019;30:213–221.
46.Chai J, Jin R, Yuan G, Kanter V, Miron RJ, Zhang Y. Effect of liquid platelet-rich fibrin and platelet-rich plasma on the regenerative potential of dental pulp cells cultured under inflammatory conditions: A comparative analysis. J Endod 2019;45:1000–1008.
47.Wang X, Yang Y, Zhang Y, Miron RJ. Fluid platelet-rich fibrin stimulates greater dermal skin fibroblast cell migration, proliferation, and collagen synthesis when compared to platelet-rich plasma. J Cosmet Dermatol 2019;18:2004–2010.
48.Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Behavior of gingival fibroblasts on titanium implant surfaces in combination with either injectable-PRF or PRP. Int J Mol Sci 2017;18:331.
49.Wang X, Zhang Y, Choukroun J, Ghanaati S, Miron RJ. Effects of an injectable platelet-rich fibrin on osteoblast behavior and bone tissue formation in comparison to platelet-rich plasma. Platelets 2018;29:48–55.
50.Miron RJ, Chai J, Zheng S, Feng M, Sculean A, Zhang Y. A novel method for evaluating and quantifying cell types in platelet rich fibrin and an introduction to horizontal centrifugation. J Biomed Mater Res A 2019;107:2257–2271.
51.Choukroun J, Ghanaati S. Reduction of relative centrifugation force within injectable platelet-rich-fibrin (PRF) concentrates advances patients’ own inflammatory cells, platelets and growth factors: The first introduction to the low speed centrifugation concept. Eur J Trauma Emerg Surg 2018;44:87–95.
52.Miron RJ, Chai J, Zhang P, et al. A novel method for harvesting concentrated platelet-rich fibrin (C-PRF) with a 10-fold increase in platelet and leukocyte yields. Clin Oral Investig 2020;24:2819–2828.
53.Varela HA, Souza JCM, Nascimento RM, et al. Injectable platelet rich fibrin: Cell content, morphological, and protein characterization. Clin Oral Investig 2019;23:1309–1318.
54.Lourenço ES, Mourão CFAB, Leite PEC, Granjeiro JM, Calasans‐Maia MD, Alves GG. The in vitro release of cytokines and growth factors from fibrin membranes produced through horizontal centrifugation. J Biomed Mater Res A 2018;106:1373–1380.
55.Strauss FJ, Nasirzade J, Kargarpoor Z, Stahli A, Gruber R. Effect of platelet-rich fibrin on cell proliferation, migration, differentiation, inflammation, and osteoclastogenesis: A systematic review of in vitro studies. Clin Oral Investig 2020;24:569–584.
56.Nasirzade J, Kargarpour Z, Hasannia S, Strauss FJ, Gruber R. Platelet-rich fibrin elicits an anti-inflammatory response in macrophages in vitro. J Periodontol 2020;91:244–252.
57.Miron RJ, Dham A, Dham U, Zhang Y, Pikos MA, Sculean A. The effect of age, gender, and time between blood draw and start of centrifugation on the size outcomes of platelet-rich fibrin (PRF) membranes. Clin Oral Investig 2019;23:2179–2185.
58.Zeng SM, Yankowitz J, Widness JA, Strauss RG. Etiology of differences in hematocrit between males and females: Sequence-based polymorphisms in erythropoietin and its receptor. J Gend Specif Med 2001;4:35–40.
59.Billett HH. Hemoglobin and hematocrit. In: Walker HK, Hall WD, Hurst JW (eds). Clinical Methods: The History, Physical, and Laboratory Examinations, ed 3. Boston: Butterworths, 1990.
Horizontal Versus Fixed-Angle Centrifugation of PRF: Optimization of C-PRF
Contributors
Richard J. Miron
Masako